Latest Articlesddd
Gilead Sciences Was Issued a CLR from the FDA for Filgotinib Gilead Sciences (GILD) is in …
CureVac is Publicy Trading on the NASDAQ CureVac is now publicly trading on the NASDAQ stock …
Sorrento Therapeutics Announcement Sorrento Therapeutics (SRNE) announced that it believes it has uncovered fraudulent attempts to …
A Predictive COVID-19 Test? COVID-19 infected people are not all affected to the same degree with …
Intellia Therapeutics Reporting operational highlights and financial results for the second quarter ended June 30, 2020, Intellia …
Seres Therapeutics Oral Microbiome Product SER-109 for Recurrent C. Difficile Infection Meets Trial Endpoint SER-109 demonstrated …
When a small firm’s stock price soars, and more than doubles, curiosity pushes us to investigate. …
Regenxbio Positive Data for RGX-314 Regenxbio (RGNX) reported positive one-year data from patients in Cohorts 4 …
Compugen Compugen (CGEN) cancer immunotherapy’s predictive target computational discovery platforms enabled it to identify two checkpoint …
Inovio Inovio’s COVID-19 Vaccine INO-4800 Accomplished the Following: Durable antibody and T cell responses in rhesus …
Edesa Biotech Filed an IND for EB05 Edesa Biotech (EDSA), a clinical-stage biopharmaceutical company, has filed …
SARS-CoV-2 Virus Vaccines Moderna On Monday Moderna (MRNA) started its Phase 3 clinical trial on 30,000 …
Gilead Sciences CAR T Cell Product Tecartus Gets FDA Approval The U.S. FDA approved Kite - …
TCR2 Therapeutics Announcement TCR2 Therapeutics (TCRR) – a clinical-stage immunotherapy company with a pipeline of novel T cell therapies …
Arbutus Biopharma and Moderna's Patent Challenge Arbutus Biopharma (ABUS) is a publicly-traded biopharmaceutical company dedicated to …
People living with narcolepsy who develop cataplexy and excessive daytime sleepiness have a new treatment called Xywav, …
Firms' with COVID-19 Vaccines Stock Performance A look at the stock performance of the COVID-19 vaccine …
Beyond the firms that are speeding towards bringing prophylactic vaccines against the COVID-19 infection into the …
Alzheimer’s Disease Alzheimer’s Disease has proven very difficult to treat through many of the trials’ attempts …
Pfizer and BioNTech Vaccines Were Granted FDA Fast Track Designation Against SARS-CoV-2 (COVID-19) A large Phase …
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it. Accept Privacy policy
